Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Giles

Showing results (441-450 of 503) with videos related to

Pageof 51
Sort By:
Mabs|May 10, 2026
Discovery, development, and characterization of SPY002 and SPY072, two novel extended half-life monoclonal antibodies targeting TL1A: in vitro properties, in vivo pharmacology, pharmacokinetics, and preclinical safetyMatthew Siegel, Eric Zhu, Daniel Rios, et al.
Cell Reports|August 15, 2019
A CEP104-CSPP1 Complex Is Required for Formation of Primary Cilia Competent in Hedgehog SignalingKari-Anne M Frikstad, Elisa Molinari, Marianne Thoresen, et al.
Leukemia|February 3, 1998
Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)R H Giles, J G Dauwerse, C Higgins, et al.
European Urology|May 23, 2018
Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled AnalysisMaxine Sun, Lorenzo Marconi, Tim Eisen, et al.
European Urology|March 29, 2022
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 UpdateBörje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al.
Cancer Treatment Reviews|September 3, 2025
Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to actionWinette T A van der Graaf, Nina S Heiss, Carolyn L Hynes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2009
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival modelsJ S Vermaat, I van der Tweel, N Mehra, et al.
European Urology|September 5, 2018
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell CarcinomaAxel Bex, Laurence Albiges, Börje Ljungberg, et al.
The Journal of Clinical Investigation|August 25, 2015
DNA replication stress underlies renal phenotypes in CEP290-associated Joubert syndromeGisela G Slaats, Joshua C Saldivar, Julien Bacal, et al.
European Urology|July 20, 2017
Recommendations for the Management of Rare Kidney CancersRachel H Giles, Toni K Choueiri, Daniel Y Heng, et al.
Pageof 51

Showing results (441-450 of 503) with videos related to

Sort By:
Pageof 51
Mabs|May 10, 2026
Discovery, development, and characterization of SPY002 and SPY072, two novel extended half-life monoclonal antibodies targeting TL1A: in vitro properties, in vivo pharmacology, pharmacokinetics, and preclinical safetyMatthew Siegel, Eric Zhu, Daniel Rios, et al.
Cell Reports|August 15, 2019
A CEP104-CSPP1 Complex Is Required for Formation of Primary Cilia Competent in Hedgehog SignalingKari-Anne M Frikstad, Elisa Molinari, Marianne Thoresen, et al.
Leukemia|February 3, 1998
Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)R H Giles, J G Dauwerse, C Higgins, et al.
European Urology|May 23, 2018
Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled AnalysisMaxine Sun, Lorenzo Marconi, Tim Eisen, et al.
European Urology|March 29, 2022
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 UpdateBörje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al.
Cancer Treatment Reviews|September 3, 2025
Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to actionWinette T A van der Graaf, Nina S Heiss, Carolyn L Hynes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2009
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival modelsJ S Vermaat, I van der Tweel, N Mehra, et al.
European Urology|September 5, 2018
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell CarcinomaAxel Bex, Laurence Albiges, Börje Ljungberg, et al.
The Journal of Clinical Investigation|August 25, 2015
DNA replication stress underlies renal phenotypes in CEP290-associated Joubert syndromeGisela G Slaats, Joshua C Saldivar, Julien Bacal, et al.
European Urology|July 20, 2017
Recommendations for the Management of Rare Kidney CancersRachel H Giles, Toni K Choueiri, Daniel Y Heng, et al.
Pageof 51